Photo: Måns Bergkvist.
Curious explorer of the world, working to make it better
Emergency physician since 2003. Cofounder of Scandinavia's first ketamine clinic and the first public ketamine treatment unit in the Norwegian hospital system.
Topics I explore
From Evidence to Practice
Available as keynote talks and workshops
Over 50 randomized controlled trials support ketamine for depression. The challenge is no longer whether it works, but how to deliver it safely, accessibly, and at scale. Drawing on a decade of building treatment programs in both private and public settings.
Ketamine-Assisted Psychotherapy
Available as keynote talks and panel discussions
1,000+ treatments across three clinics since 2018. We combine ketamine with structured psychotherapy for treatment-resistant depression, PTSD, addiction, and eating disorders.
The Nordic Model
Available as keynote talks and fireside conversations
Norway became the first country to approve national public reimbursement for generic ketamine treatment. This is how we built the clinical infrastructure that made it possible.
Emergency Medicine in Space
Available as keynote talks and fireside conversations
Before ketamine, I studied how to perform emergency medical procedures in microgravity. A detour into space medicine at the Institute for Biomedical Problems in Moscow that shaped how I think about working at the edges of what is known.
“His leadership culminated in a historic milestone: Norway became the first country worldwide to include racemic ketamine in national treatment guidelines with public healthcare funding.”
Photo: Måns Bergkvist
Projects I’m involved in
Building clinical infrastructure, research networks, and professional organizations across Scandinavia.
NorRAD
National network of consultant psychiatrists that designed the ten-hospital trial behind Norway's 2025 decision to publicly fund ketamine treatment.
PsykForsk, Sykehuset Ostfold
Established Scandinavia's first public hospital ketamine unit and oversaw Norway's first MDMA-assisted psychotherapy trial.
University of Oslo Psychedelic Research
Collaborating on psychedelic phenomenology studies and neuroscience research at the University of Oslo.
UNN Ketamine Trial
Randomized controlled trial of ketamine for depression with comorbid alcohol dependence, in collaboration with Dr. Andreas Blomkvist.
Axon Research Foundation
Foundation funding ketamine treatment for veterans, healthcare workers, and trauma survivors, alongside clinical research.
Oslo New University College (ONH)
Research collaboration investigating ketamine-assisted psychotherapy for eating disorders.
Swipe to see more
Selected work
VideoKetamine: The Psychedelic Elephant in the Room
Eden Foundation · 7 Feb 2026Watch
VideoKetamine for Depression and Reconnection
Transformative New Mexico · 11 Jun 2020Watch
PodcastBorealis 2025: Lowan Stewart
Psykedelisk Vetenskap · 17 Nov 2025Listen
PodcastKetamin, spiseforstyrrelser og psykiske lidelser
Psykt Interessant · 27 Oct 2025Listen
ArticleOff-label ketamine for treatment resistant depression
The Nordic Psychiatrist · 6 Dec 2025Read
ArticleFørst i verden: Psykedelisk medisin godkjent i Norge
Aftenposten · 25 Aug 2025Read